Volkan Granit

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

Volkan Granit, Michael Benatar, Metin Kurtoğlu et al. · The Lancet Neurology · 2023 · 216 citations · Full text

Allergy, Autoimmune Disease, Non-randomised Phase 1B/2a +6

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

Michael Benatar, Joanne Wuu, Caroline McHutchison et al. · Brain · 2021 · 109 citations · Full text

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Alzheimer's Disease +13

Current treatment practice of Guillain-Barré syndrome

Christine Verboon, Alex Y. Doets, Giuliana Galassi et al. · Neurology · 2019 · 87 citations · Full text

An International Perspective on Preceding Infections in Guillain-Barré Syndrome

Sonja E. Leonhard, Annemiek A. van der Eijk, Henning Andersen et al. · Neurology · 2022 · 76 citations · Full text

Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study

Linda W.G. Luijten, Sonja E. Leonhard, Annemiek A. van der Eijk et al. · Brain · 2021 · 72 citations · Full text

Recruitment Bias, World Health Organization, Long Covid +12